Relative Bioavailability, Safety and Tolerability of Two Tablet Formulations of BIIL 284 BS
Clinical trial NCT02265666 · COMPLETED
Trial details
- NCT number
- NCT02265666
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2001-10-01
- Primary completion
- 2001-11-01
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.